Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3030726 | Trends in Cardiovascular Medicine | 2006 | 5 Pages |
Abstract
The Lectin-like OXidized low-density lipoprotein scavenger receptor (LOX-1) is implicated in vascular inflammation and atherosclerotic plaque initiation, progression, and destabilization. LOX-1 levels are elevated upon recognition of oxidized low-density lipoprotein, a key pro-atherogenic substance in the vasculature. Recent evidence indicates this gene product is a biomarker of inflammation and disease status. We review and assess the role of LOX-1 in atherosclerotic plaque formation, physiologic regulation, and as a biomarker and target in cardiovascular disease diagnosis and prevention.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ravinder S. Vohra, Jane E. Murphy, John H. Walker, Sreenivasan Ponnambalam, Shervanthi Homer-Vanniasinkam,